XML 47 R34.htm IDEA: XBRL DOCUMENT v3.25.1

RESTRUCTURING (Tables)

12 Months Ended

Mar. 29, 2025

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Transformation Costs by Type of Cost

The following table summarizes the activity for restructuring reserves related to the portfolio rationalization initiatives, 2020 Program and market and regional alignment initiative for the fiscal years ended March 29, 2025, March 30, 2024 and April 1, 2023, substantially all of which relates to employee severance, other employee costs, inventory reserves and lease termination fees:

(In thousands)			Portfolio Rationalization						2020 Program						Market and Regional Alignment						Prior Programs						Total
Balance at April 2, 2022			$	—					$	2,460					$	—					$	345					$	2,805
Costs incurred, net of reversals			—						576						—						81						657
Payments			—						(1,226)						—						(86)						(1,312)
Balance at April 1, 2023			$	—					$	1,810					$	—					$	340					$	2,150
Costs incurred, net of reversals			13,915						450						—						(276)						14,089
Payments			(2,606)						(1,775)						—						(64)						(4,445)
Balance at March 30, 2024			$	11,309					$	485					$	—					$	—					$	11,794
Costs incurred, net of reversals			12,797						566						550						—						13,913
Payments			(12,755)						(761)						(550)						—						(14,066)
Non-cash adjustments			(8,616)						—						—						—						(8,616)
Balance at March 29, 2025			$	2,735					$	290					$	—					$	—					$	3,025

The following presents the restructuring costs by line item during fiscal 2025, 2024 and 2023 within our accompanying consolidated statements of income and comprehensive income:

(In thousands)			2025						2024						2023
Cost of goods sold			$	11,328					$	11,286					$	(215)
Research and development			(61)						456						—
Selling, general and administrative expenses			2,646						2,347						872
Total			$	13,913					$	14,089					$	657

Restructuring and Related Costs by Segment

The following presents the restructuring related costs by line item during fiscal 2025, 2024 and 2023 within our accompanying consolidated statements of income and comprehensive income:

(In thousands)			2025						2024						2023
Cost of goods sold			$	3,304					$	5,734					$	7,991
Research and development			1,649						1,750						1,050
Selling, general and administrative expenses			2,292						2,015						1,851
Total			$	7,245					$	9,499					$	10,892

The tables below present restructuring and restructuring related costs by reportable segment:

Restructuring costs
(In thousands)			2025						2024						2023
Plasma			$	258					$	1,015					$	(48)
Blood Center			4,742						5,606						—
Hospital			1,664						3,863						165
Corporate			7,249						3,605						540
Total			$	13,913					$	14,089					$	657
Restructuring related costs
(In thousands)			2025						2024						2023
Plasma			$	281					$	1,050					$	1,385
Blood Center			154						286						75
Hospital			143						408						546
Corporate			6,667						7,755						8,886
Total			$	7,245					$	9,499					$	10,892
Total restructuring and restructuring related costs			$	21,158					$	23,588					$	11,549

X

- References

No definition available.

+ Details

Name:	us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 420
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 5.P.3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479823/420-10-S99-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 420
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482017/420-10-50-1

+ Details

Name:	us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 420
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4.b.2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482017/420-10-50-1

+ Details

Name:	us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration